Cite
HARVARD Citation
Takeshima, T. et al. (2021). Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study. Headache. 61 (6), pp. 927-935. [Online].